At a glance
- Originator Merck & Co
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 20 Mar 1995 No-Development-Reported for HIV-1 infections in USA (Unknown route)
- 12 Oct 1994 Preclinical development for HIV-1 infections in USA (Unknown route)